GLAXOSMITHKLINE PHARMACEUTICALS
Back to Income Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹590 Cr | ₹611 Cr | ₹1,695 Cr | ₹358 Cr | ₹93 Cr |
What is the latest Consolidated Net Profit of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Consolidated Net Profit |
---|---|
Mar2025 | ₹590 Cr |
Mar2024 | ₹611 Cr |
Mar2023 | ₹1,695 Cr |
Mar2022 | ₹358 Cr |
Mar2021 | ₹93 Cr |
How is Consolidated Net Profit of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2025 | ₹590 Cr | -3.39 | |
Mar2024 | ₹611 Cr | -63.97 | |
Mar2023 | ₹1,695 Cr | 373.19 | |
Mar2022 | ₹358 Cr | 284.26 | |
Mar2021 | ₹93 Cr | - |
Compare Consolidated Net Profit of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹54,206.3 Cr | -2.2% | -3.4% | 28.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹414,533.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,215.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹120,428.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹116,410.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,253.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | -2.2% |
-3.4% |
28.9% |
SENSEX | -1.4% |
1.8% |
3.3% |
You may also like the below Video Courses